Current Developments and Future Prospects for Plant-Made Biopharmaceuticals Against Rabies Review uri icon

abstract

  • Rabies is a prevalent health problem in developing countries. Although vaccines and immunoglobulin treatments are available, their cost and multiple-dose treatments restrict availability. During the last two decades, plants have served as a low-cost platform for biopharmaceuticals production and have been applied to fight against rabies during the last two decades. Herein, I provide a description of the state of the art in the development of plant-made pharmaceuticals against rabies and identify key prospects for the field in terms of novel strategies, immunogen design, and therapeutic antibodies production. © 2015, Springer Science%2bBusiness Media New York.

publication date

  • 2015-01-01